Resources
About Us
Home Report
Store
Protein Expression Market
Protein Expression Market by System (Mammalian [CHO, HEK 293], Non-mammalian [Bacterial, Insect, Yeast]), Offering (Kits & Reagents, Vectors, Competent Cells, Services), Application (Industrial, Therapeutic, Research), and End User - Global Forecast to 2030
Report ID:MRHC - 104932 Pages: 270 Jul-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursProtein Expression Market is projected to reach $5 billion by 2030, at a CAGR of 7.6% from 2024 to 2030. Protein expression is the process of synthesizing an unnaturally occurring protein (heterologous protein) by introducing recombinant DNA into the host cell. For this, prokaryotic and eukaryotic are used depending on economic and qualitative aspects, such as the type of protein, function, and desired protein yield. These systems are used for therapeutic, research, or industrial purposes.
The increasing biopharmaceutical market, growing demand for recombinant proteins, rising government initiatives, and funding for life science research are driving the growth of this market. Furthermore, the potential emerging economies are expected to offer significant growth opportunities for the protein expression market.
However, the high cost of protein-based research and the lack of skilled professionals are expected to restrain the growth of this market. Additionally, complexities in laboratory transformation parameters are challenging the growth of this market.
Expansion of Biopharma Companies for Production of Biosimilars to Drive the Demand for Protein Expression Market
Biosimilars are gaining significant importance in oncology, autoimmune diseases, and rare diseases. The price advantage of biosimilars compared to biologics and the biosimilar substitution laws are boosting the demand for biosimilars. Several manufacturers are expanding their manufacturing facilities to meet the growing demand for biopharmaceuticals. The COVID-19 pandemic also resulted in the facility expansion of vaccine manufacturing plants. These capacity expansions from biopharmaceutical manufacturers and CDMOs will generate additional demand for biopharmaceutical-related products. For instance,
-
In December 2021, Biocon Ltd. (India) and Mylan N.V. (U.S.) planned to combine their biosimilar businesses to create a larger company.
- In December 2021, FUJIFILM Diosynth Biotechnologies (U.S.) announced an investment of USD 350 million to add a current Good Manufacturing Practice (cGMP) production facility at its U.S. plant to increase the production of vaccine manufacturing and advanced therapy.
Biosimilars need to be identical to the biological source; hence the use of protein expression of interest is essential for their production process. Thus, increasing biosimilar production drives the demand for protein expression systems.
Click here to: Get Free Sample Pages of this Report
Emerging Economies Provide Opportunity for the Players in the Market
Developed economies like the U.S. and European countries have contributed greatly to the biopharmaceutical market. These markets are relatively better penetrated, and thus, players in this market are increasingly shifting their focus to underpenetrated emerging economies. Emerging countries in Asia and Latin America offers high growth opportunities attributed to the growing demand for biopharmaceutical products, increasing aging population suffering from chronic and infectious diseases, rising pharmaceutical R&D expenditure, growing demand for biologics, and growing disposable income.
Rising public & private funding for R&D and rising contract research and manufacturing activities support the biopharmaceutical industry's growth across China, India, and the Association of Southeast Asian Nations (ASEAN) member countries in the Asia-Pacific region, Brazil, and Mexico in Latin America. The rising demand for biopharmaceuticals and growing pressure to curtail the high development cost are compelling the biopharmaceutical industries to outsource research, development, and manufacturing to minimize cost and save time. Due to this, CDMOs in emerging nations are experiencing a high growth rate and are actively involved in the production and development of biopharmaceuticals. This is attributed to growing infrastructure and capacity development investments, low labor costs, improving adherence to global manufacturing standards, and increasing regulatory oversight.
The development of biosimilar therapeutics is gaining pace in developing economies like China and India. China is experiencing a spike in biopharmaceutical development. The Chinese government has undertaken several initiatives to develop and commercialize biosimilars. Some of these initiatives include developing multinational clinical centers and accelerating the approval process for special medicines. The introduction of the Marketing Authorization Holder (MAH) plan to launch biosimilars in China has allowed license holders to sell biosimilars through contract manufacturing.
These initiatives in emerging economies for bioproduction or research provide an opportunity for a higher demand for protein expression systems.
Key Findings in the Protein Expression Market Study:
In 2024, the Mammalian Cell Expression System Segment is Expected to Dominate the Market
Among the system type, the mammalian cell expression system segment is expected to account for the largest share of this market. This segment’s large market share is attributed to advantages like the low risk of cross-contamination, no need for post-translational modification, and wider acceptance for therapeutic applications.
In 2024, the Reagents Segment is Expected to Dominate the Market
Based on products & services, the protein expression market is segmented into instruments, kits & reagents, competent cells, expression vectors, and services. In 2024, the reagents segment is expected to account for the largest share of the protein expression market. The large market share of this segment is attributed to factors such as frequent use of them for research, therapeutics, or industrial purposes.
In 2024, the Research Segment is Expected to Exhibit Highest CAGR
Among the application, the research segment is expected to grow at the highest CAGR in the protein expression market. Factors such as a growing R&D expenditure, the emergence of new diseases, and a focus on pharma-academic collaboration for boosting research supported the growth of the market.
In 2024, the Contract Research Organizations Segment is Expected to Exhibit Highest CAGR
Based on end user, the protein expression market is segmented into pharmaceutical & biotechnology industry, contract research organizations, and academic & research institutes. In 2024, the contract research organizations segment is expected to exhibit the highest CAGR owing to the growing focus of many vendors on outsourcing and government initiatives for expanding research activities.
Asia-Pacific: Fastest-growing Regional Market
The growth of this market is driven by the increasing investments in life science research in developing countries such as China and India, and the growing preference for recombinant technology owing to advantages such as low risk of immune reaction, no interference of protein contaminants, and short production lead times as there is no need of purification process in recombinant technology. Thus, compared to traditional technology, recombinant is driving the growth of the protein expression market in Asia-Pacific.
Key Players:
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market players in the past few years. The key players profiled in the protein expression market report are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Takara Holdings Inc. (Japan), GenScript Biotech Corporation (U.S.), Qiagen N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), and BECTON, DICKINSON AND COMPANY (U.S.).
Scope of the Report:
Protein Expression Market Assessment, by System
- Mammalian Cell Expression System
- Chinese Hamster Ovary (CHO) Cell Lines
- HEK 293 Cell Lines
- Other Mammalian Cell Lines
- Non-mammalian Cell Expression System
- Bacterial Cell Lines
- Insect Cell Lines
- Yeast Cell Lines
- Plant Cell Lines
- Algal-based Cell Lines
- Cell-Free Expression System
(Note: Other mammalian cell expression system includes Baby Hamster Kidney Cells, Non-secreting Murine Myeloma cells, and PER.C6.)
Protein Expression Market Assessment, by Product & Service
- Instruments
- Kits & Reagents
- Competent Cells
- Chemically Competent Cells
- Electrocompetent Cells
- Expression Vectors
- Services
Protein Expression Market Assessment, by Application
- Therapeutic
- Research
- Industrial
Protein Expression Market Assessment, by End User
- Pharmaceutical & Biotechnology Industry
- Academic & Research Institutes
- Contract Research Organizations (CROs)
Protein Expression Market Assessment, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- U.K.
- Spain
- Rest of Europe (RoE)
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
Key questions answered in the report:
This study offers a detailed assessment of the protein expression market and analyzes the market sizes & forecasts based on system type, product & service, application, and end user. This report also involves the value analysis of various segments and subsegments of the protein expression market at the regional and country levels.
The protein expression market is projected to reach $5 billion by 2030, at a CAGR of 7.6% during the forecast period.
Based on type, in 2024, the mammalian cell expression system is expected to account for the largest share of the market due to the low risk of cross-contamination or host rejection.
Based on application, the research segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the focus on expanding research activities through academia-pharma collaborations.
The increasing biopharmaceutical market, growing demand for recombinant proteins, and rising government initiatives and funding for life science research are driving the growth of this market. Furthermore, the potential emerging economies are expected to offer significant growth opportunities for the protein expression market.
The key players profiled in the protein expression market study are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Takara Holdings Inc. (Japan), GenScript Biotech Corporation (U.S.), Qiagen N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), and BECTON, DICKINSON AND COMPANY (U.S.).
Emerging economies such as China and India are projected to offer significant growth opportunities to the market players due to rising R&D expenditure, focusing on academia-pharma collaborations for bioproduction, and the high market expansion potential in these countries.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Growth in the Biopharmaceutical Market
4.2.2. Growing Demand for Recombinant Proteins
4.2.3. Rising Government Initiatives and Funding for Life Science Research
4.3. Restraints
4.3.1. Shortage of Skilled Professionals
4.3.2. High Cost of Protein-based Research
4.4. Opportunities
4.4.1. Potential Emerging Economies
4.5. Challenges
4.5.1. Complexities in Laboratory Transformation Parameters
4.6. Industry Trends
4.7. Parent/Adjacent Market Analysis
4.8. Regulatory Analysis
5. Protein Expression Market Assessment—by System
5.1. Overview
5.2. Mammalian Cell Expression System
5.2.1. Chinese Hamster Ovary (CHO) Cell Lines
5.2.2. HEK 293 Cell Lines
5.2.3. Other Mammalian Cell Lines
5.3. Non-mammalian Cell Expression System
5.3.1. Bacterial Cell Lines
5.3.2. Insect Cell Lines
5.3.3. Yeast Cell Lines
5.3.4. Plant Cell Lines
5.3.5. Algal Cell Lines
5.4. Cell-Free Expression System
6. Protein Expression Market Assessment—by Product & Services
6.1. Overview
6.2. Instruments
6.3. Kits & Reagents
6.4. Competent Cells
6.4.1. Chemically Competent Cells
6.4.2. Electrocompetent Cells
6.5. Expression Vectors
6.6. Services
7. Protein Expression Market Assessment—by Application
7.1. Overview
7.2. Therapeutic Application
7.3. Industrial Application
7.4. Research Application
8. Protein Expression Market Assessment—by End User
8.1. Introduction
8.2. Pharmaceutical and Biotechnology Industry
8.3. Contract Research Organizations (CROs)
8.4. Academic and Research Institutes
9. Protein Expression Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4 Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis (2022)
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Thermo Fisher Scientific Inc.
11.2. Promega Corporation
11.3. Merck KGaA
11.4. Bio-Rad Laboratories, Inc.
11.5. Takara Holdings Inc.
11.6. GenScript Biotech Corporation
11.7. Qiagen N.V.
11.8. Agilent Technologies, Inc.
11.9. Danaher Corporation
11.10. BECTON, DICKINSON AND COMPANY
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Protein Expression Market Drivers: Impact Analysis (2024–2030)
Table 2 Global Protein Expression Market Restraint: Impact Analysis (2024–2030)
Table 3 Global Protein Expression Market Restraints: Impact Analysis (2024–2030)
Table 4 Global Protein Expression Market Opportunities: Impact Analysis (2024–2030)
Table 5 Global Protein Expression Market Challenges: Impact Analysis (2024–2030)
Table 6 Global Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 7 Global Mammalian Cell Expression System Market, by Type, 2021–2030 (USD Million)
Table 8 Global Mammalian Cell Expression System Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Vendors Offering Mammalian Cell Expression System
Table 10 Global Chinese Hamster Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global HEK 293 Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Other Mammalian Cell Expression System Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Non-mammalian Cell Expression System Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Bacterial Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Insect Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Yeast Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Plant Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Algal Cell Lines Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Cell-free Expression System Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Other Expression Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 22 Global Instruments Market for Protein Expression, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Kits & Reagents Market for Protein Expression, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 25 Global Chemically Competent Cells Market for Protein Expression, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Electrocompetent Cells Market for Protein Expression, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Expression Vectors Market for Protein Expression, by Country/Region, 2021–2030 (USD Million)
Table 28 Global Protein Expression Services Market, by Country/Region, 2021–2030 (USD Million)
Table 29 Global Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 30 Global Protein Expression Market for Therapeutics, by Country/Region, 2021–2030 (USD Million)
Table 31 Global Protein Expression Market for Research, by Country/Region, 2021–2030 (USD Million)
Table 32 Global Protein Expression Market for Industrial, by Country/Region, 2021–2030 (USD Million)
Table 33 Global Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 34 Global Protein Expression Market for Pharmaceutical and Biotechnology Industry, by Type, 2021–2030 (USD Million)
Table 35 Global Protein Expression Market for Contract Research Organizations, by Country/Region, 2021–2030 (USD Million)
Table 36 Global Protein Expression Market for Academic and Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 37 Global Protein Expression Market, by Country/Region, 2021–2030 (USD Million)
Table 38 North America: Protein Expression Market, by Country, 2021–2030 (USD Million)
Table 39 North America: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 40 North America: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 41 North America: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 42 North America: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 43 North America: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 44 North America: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 45 North America: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 46 U.S.:Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 47 U.S.: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 48 U.S.: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 49 U.S.: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 50 U.S.: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 51 U.S.: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 52 U.S.: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 53 Canada: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 54 Canada: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 55 Canada: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 56 Canada: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 57 Canada: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 58 Canada: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 59 Canada: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 60 Europe: Protein Expression Market, by Country, 2021–2030 (USD Million)
Table 61 Europe: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 62 Europe: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 63 Europe: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 64 Europe: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 65 Europe: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 66 Europe: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 67 Europe: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 68 Germany: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 69 Germany: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 70 Germany: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 71 Germany: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 72 Germany: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 73 Germany: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 74 Germany: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 75 France: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 76 France: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 77 France: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 78 France: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 79 France: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 80 France: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 81 France: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 82 U.K.: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 83 U.K.: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 84 U.K.: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 85 U.K.: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 86 U.K.: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 87 U.K.: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 88 U.K.: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 89 Italy: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 90 Italy: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 91 Italy: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 92 Italy: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 93 Italy: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 94 Italy: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 95 Italy: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 96 Spain: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 97 Spain: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 98 Spain: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 99 Spain: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 100 Spain: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 101 Spain: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 102 Spain: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 103 RoE: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 104 RoE: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 105 RoE: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 106 RoE: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 107 RoE: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 108 RoE: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 109 RoE: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 110 APAC: Protein Expression Market, by Country, 2021–2030 (USD Million)
Table 111 APAC: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 112 APAC: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 113 APAC: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 114 APAC: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 115 APAC: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 116 APAC: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 117 APAC: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 118 Japan: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 119 Japan: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 120 Japan: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 121 Japan: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 122 Japan: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 123 Japan: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 124 Japan: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 125 China: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 126 China: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 127 China: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 128 China: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 129 China: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 130 China: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 131 China: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 132 India: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 133 India: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 134 India: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 135 India: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 136 India: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 137 India: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 138 India: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 139 RoAPAC: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 140 RoAPAC: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 141 RoAPAC: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 142 RoAPAC: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 143 RoAPAC: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 144 RoAPAC: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 145 RoAPAC: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 146 Latin America: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 147 Latin America: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 148 Latin America: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 149 Latin America: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 150 Latin America: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 151 Latin America: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 152 Latin America: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 153 Middle East & Africa: Protein Expression Market, by System Type, 2021–2030 (USD Million)
Table 154 Middle East & Africa: Mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 155 Middle East & Africa: Non-mammalian Cell Expression Systems Market, by Type, 2021–2030 (USD Million)
Table 156 Middle East & Africa: Protein Expression Market, by Product & Service, 2021–2030 (USD Million)
Table 157 Middle East & Africa: Competent Cells Market for Protein Expression, by Type, 2021–2030 (USD Million)
Table 158 Middle East & Africa: Protein Expression Market, by Application, 2021–2030 (USD Million)
Table 159 Middle East & Africa: Protein Expression Market, by End User, 2021–2030 (USD Million)
Table 160 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Estimation
Figure 7 Global Protein Expression Market, by System Type, 2024 Vs. 2030 (USD Million)
Figure 8 Global Protein Expression Market, by Product & Service, 2024 Vs. 2030 (USD Million)
Figure 9 Global Protein Expression Market, by Application, 2024 Vs. 2030 (USD Million)
Figure 10 Global Protein Expression Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 11 Global Protein Expression Market, by Geography, 2024 Vs. 2030 (USD Million)
Figure 12 North America: Protein Expression Market Snapshot
Figure 13 Asia-Pacific: Protein Expression Market Snapshot
Figure 14 Europe: Protein Expression Market Snapshot
Figure 15 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 16 Protein Expression: Competitive Benchmarking, by System Type
Figure 17 Protein Expression: Competitive Benchmarking, by Geography
Figure 18 Market Share Analysis: Protein Expression Industry, 2022
Figure 19 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 20 Promega Corporation: Financial Overview (2022)
Figure 21 Merck KGaA: Financial Overview (2022)
Figure 22 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 23 Takara Holdings Inc.: Financial Overview (2022)
Figure 24 GenScript Biotech Corporation: Financial Overview (2022)
Figure 25 Qiagen N.V.: Financial Overview (2022)
Figure 26 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 27 Danaher Corporation: Financial Overview (2022)
Figure 28 BECTON, DICKINSON AND COMPANY: Financial Overview (2022)
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Protein Assays Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Mar-2024
Competent Cells Market - Global Opportunity Analysis and Industry Forecast (2018-2023)
Published Date: Feb-2018
Clinical Trials Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
Microarray Kits Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Feb-2024
